buprenorphine

FDA Drug Profile — SUBLOCADE, buprenorphine transdermal system, Butrans

buprenorphine is listed in the FDA National Drug Code directory with 18 NDC codes, marketed under brand names including SUBLOCADE, buprenorphine transdermal system, Butrans. Available dosage forms: solution, patch, extended release.

Drug details

Generic Name
buprenorphine
Brand Names
SUBLOCADE, buprenorphine transdermal system, Butrans
Application Number
NDA209819
Sponsor
Indivior Inc.
NDC Codes
18
Dosage Forms
SOLUTION, PATCH, EXTENDED RELEASE
Routes
SUBCUTANEOUS, TRANSDERMAL
Active Ingredients
BUPRENORPHINE

Indications and Usage

1 INDICATIONS AND USAGE SUBLOCADE is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine. SUBLOCADE should be used as part of a complete treatment plan that includes counseling and psychosocial support. SUBLOCADE contains buprenorphine, a partial opioid agonist, and is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine. ( 1 ) SUBLOCADE should be used as part of a complete treatment program that includes counseling and psychosocial support. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.